Every open market buy and sale of RenovoRx, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are buying over the last 12 months: $131K bought and $0 sold.
Buying and selling by month
open market, last 12 monthsGet an alert when RNXT insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an RNXT officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every RNXT insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Ramtin AgahExecutive Chairman and CMO | Buy | 50,000 | $0.93 | $46K | 848,460 | Nov 17Form 4 |
| May 19, 2026 | Mark VollCFO | Buy | 25,000 | $0.79 | $20K | 142,380 | May 21Form 4 |
| Jan 21, 2026 | Ramtin AgahChief Medical Officer | Buy | 10,000 | $1.00 | $10K | 798,460 | Jan 22Form 4 |
| Dec 31, 2025 | Ramtin AgahChief Medical Officer | Buy | 9,795 | $0.86 | $8K | 788,460 | Jan 5Form 4 |
| Dec 30, 2025 | Ramtin AgahChief Medical Officer | Buy | 205 | $0.83 | $170 | 778,665 | Jan 2Form 4 |
| Dec 18, 2025 | Shaun BagaiCEO | Buy | 5,000 | $0.90 | $5K | 340,040 | Dec 22Form 4 |
| Dec 17, 2025 | Shaun BagaiCEO | Buy | 5,000 | $0.85 | $4K | 335,040 | Dec 19Form 4 |
| Dec 16, 2025 | Ramtin AgahChief Medical Officer | Buy | 12,000 | $0.85 | $10K | 778,460 | Dec 17Form 4 |
| Dec 5, 2025 | Ramtin AgahChief Medical Officer | Buy | 10,000 | $0.96 | $10K | 766,460 | Dec 8Form 4 |
| Nov 24, 2025 | Ramtin AgahChief Medical Officer | Buy | 22,000 | $0.80 | $18K | 756,460 | Nov 24Form 4 |
| Aug 25, 2025 | Shaun BagaiCEO | Buy | 10,000 | $0.93 | $9K | 330,040 | Aug 26Form 4 |
| Jun 5, 2025 | Ramtin AgahChief Medical Officer | Buy | 21,000 | $1.40 | $29K | 734,460 | Jun 9Form 4 |
| Apr 15, 2025 | Ramtin AgahChief Medical Officer | Buy | 15,000 | $0.90 | $14K | 1,113,460 | Apr 17Form 4 |
| Apr 15, 2025 | Shaun BagaiCEO | Buy | 7,500 | $0.91 | $7K | 320,040 | Apr 16Form 4 |
| Apr 11, 2025 | Ramtin AgahChief Medical Officer | Buy | 20,000 | $0.80 | $16K | 1,098,460 | Apr 14Form 4 |
RNXT insider trading FAQ
Are RNXT insiders buying or selling?
Insiders are buying over the last 12 months. 3 insiders bought $131K of RNXT on the open market in 10 trades, and 0 sold $0 in 0 trades.
When did an RNXT insider last buy shares?
Ramtin Agah (Executive Chairman and CMO) bought 50,000 shares for $46K on Nov 16, 2026, reported on Nov 17, 2026.
When did an RNXT insider last sell shares?
There has been no open market insider sale of RNXT in the last two years.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
